Omeros Corporation (OMER) by event type
OMER moves most on analyst upgrades — a median of +0.58% at 30 minutes across 18 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the OMER overview →
How OMER reacts across 3 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 299 of 2,717 | 18 | +0.58% | 67% | +0.25% |
| Analyst downgrades 2,258 of 2,603 | 17 | -0.57% | 35% | -1.71% |
| Rating reiterations 158 of 3,522 | 69 | +0.49% | 58% | +0.32% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 3 further classes were observed with fewer than 10 measured events and are not published.
That’s how OMER usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Rating reiterations → · OMER overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Catalent, Inc. (CTLT) | 232 | +0.10% | 62% |
| Dyadic International, Inc. (DYAI) | 232 | 0.00% | 45% |
| SANUWAVE Health, Inc. (SNWV) | 232 | 0.00% | 49% |
| Bio-Rad Laboratories, Inc. Class A (BIO) | 231 | -0.06% | 46% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.